Alto Ingredients, Inc. (ALTO)
Price:
1.11 USD
( - -0.03 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Green Plains Inc.
VALUE SCORE:
6
2nd position
WD-40 Company
VALUE SCORE:
8
The best
Gevo, Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Production, and Other Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages, flavor extracts, and vinegar, as well as corn germ used in corn oils and carbon dioxide for food and beverage markets; and essential ingredients include dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed for commercial animal feed and pet food applications. The company also provides fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, it offers transportation, storage, and delivery services through third-party service providers. The company sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry and biodiesel customers. It operates five alcohol production facilities, including three plants in the Midwestern states of Illinois; and two facilities located in the Western states of Oregon and Idaho. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.
NEWS

Alto Ingredients, Inc. to Present in the LD Micro Main Event XIX
globenewswire.com
2025-10-07 08:30:00PEKIN, Ill., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the LD Micro Main Event XIX on Tuesday, October 21, 2025, in San Diego.

Alto Ingredients Applauds Passage of Assembly Bill 30 Expanding E15 Fuel Options in California
globenewswire.com
2025-10-06 08:30:00PEKIN, Ill., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, welcomes the signing of Assembly Bill 30 by Governor Gavin Newsom, authorizing the sale of E15 fuel, a gasoline blend that contains 15% ethanol, throughout California. This landmark legislation makes it possible for Alto Ingredients and the broader renewable fuels industry to meet the growing demand for more affordable, domestically produced ethanol blends while supporting the state's clean energy goals.

Alto Ingredients, Inc. to Present in the 27th Annual H.C. Wainwright Global Investment Conference
globenewswire.com
2025-09-02 16:05:00PEKIN, Ill., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025, in New York City.

Victoria's Secret Has Opened Its New Flagship Store in Miami Beach, Marking a Bold New Chapter for the Iconic Brand
businesswire.com
2025-08-19 10:18:00MIAMI--(BUSINESS WIRE)--ALTO Real Estate Funds announced the opening of Victoria's Secret's flagship store. After relocating from a nearby site, Victoria's Secret secured a 12-year lease with ALTO Real Estate Funds — a move that underscores the strength of this premier property and Lincoln Road's global appeal. ALTO acquired the retail asset four years ago, during the height of the pandemic. Today, with Victoria's Secret anchoring the location, the property reflects the corridor's resurgence an.

Alto Ingredients, Inc. (ALTO) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-06 21:21:55Alto Ingredients, Inc. (NASDAQ:ALTO ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Bryon T. McGregor - CEO, President & Director Robert R.

Alto Ingredients (ALTO) Reports Q2 Loss, Beats Revenue Estimates
zacks.com
2025-08-06 18:21:09Alto Ingredients (ALTO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.05 per share a year ago.

Alto Ingredients, Inc. Reports Second Quarter 2025 Results
globenewswire.com
2025-08-06 16:05:00- Western Assets Increased Gross Profit by $5.6 Million, Compared to Q2 2024 - PEKIN, Ill., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended June 30, 2025.

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203
businesswire.com
2025-06-26 07:33:00MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the identification of a patient selection biomarker and positive pharmacodynamic results from its exploratory Phase 2 proof-of-concept (POC) trial of ALTO-203 in major depressive disorder (MDD) patients with elevated levels of anhedonia. ALTO-203 is a novel, oral, h.

Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder
businesswire.com
2025-05-29 08:03:00MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, in Scottsdale, Arizona, held May 27-30, 2025. ALTO-300, also known as agomelatine, is an oral, small molecule designed to act as a melatonin agonist and 5-HT2C antagonist be.

Alto Ingredients, Inc. (ALTO) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-05-07 22:50:45Alto Ingredients, Inc. (NASDAQ:ALTO ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations, Alliance Advisors IR Bryon McGregor - President & Chief Executive Officer Rob Olander - Chief Financial Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Operator Good day, and welcome to the Alto Ingredients First Quarter 2025 Financial Results Conference Call.

Alto Ingredients (ALTO) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
2025-05-07 19:20:36Alto Ingredients (ALTO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.17 per share a year ago.

Alto Ingredients, Inc. Reports First Quarter 2025 Results
globenewswire.com
2025-05-07 16:05:00- Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA -

Alto Ingredients, Inc. to Release First Quarter 2025 Financial Results on May 7, 2025
globenewswire.com
2025-05-01 08:30:00PEKIN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its first quarter 2025 financial results after the close of market on Wednesday, May 7, 2025.

Alto Ingredients, Inc. Directors to Not Stand for Reelection
globenewswire.com
2025-03-18 08:10:00PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that two long-standing directors, Douglas L. Kieta and Michael D. Kandris, have decided they will not stand for reelection to the Alto Ingredients Board of Directors at the company's 2025 Annual Meeting of Stockholders, scheduled for June 25, 2025.

Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok
globenewswire.com
2025-03-18 08:00:00PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that it has entered into a letter agreement (the “Letter Agreement”) with Bradley L. Radoff and Michael Torok (collectively with their affiliates, the “Radoff/Torok Group”), under which the Radoff/Torok Group has agreed that during the period commencing on the date of the Letter Agreement until the date that is the earlier to occur of (i) thirty (30) days prior to the deadline for delivery of notice under the Company's Amended and Restated Bylaws for the nomination of director candidates for election to the Board of Directors (the “Board”) at Alto Ingredients, Inc.'s (the “Company”) 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) or (ii) one hundred twenty (120) days prior to the first anniversary of the 2025 Annual Meeting of Stockholders of the Company, currently scheduled for June 25, 2025 (the “Standstill Period”), at each annual or special meeting of the stockholders of the Company, the Radoff/Torok Group will cause all shares of the Company's common stock beneficially owned by it in favor of all directors nominated by the Board for election and otherwise in accordance with the recommendations of the Board, and against the election of any director nominee not so recommended by the Board.

Alto Ingredients, Inc. (ALTO) Q4 2024 Earnings Call Transcript
seekingalpha.com
2025-03-05 19:13:24Alto Ingredients, Inc. (NASDAQ:ALTO ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors IR Bryon McGregor - President and CEO Rob Olander - CFO Conference Call Participants Sameer Joshi - H.C. Wainwright Eric Stine - Craig-Hallum Operator Good evening, and welcome to the Alto Ingredients Fourth Quarter and Year-End 2024 Financial Results Conference Call.
No data to display

Alto Ingredients, Inc. to Present in the LD Micro Main Event XIX
globenewswire.com
2025-10-07 08:30:00PEKIN, Ill., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the LD Micro Main Event XIX on Tuesday, October 21, 2025, in San Diego.

Alto Ingredients Applauds Passage of Assembly Bill 30 Expanding E15 Fuel Options in California
globenewswire.com
2025-10-06 08:30:00PEKIN, Ill., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, welcomes the signing of Assembly Bill 30 by Governor Gavin Newsom, authorizing the sale of E15 fuel, a gasoline blend that contains 15% ethanol, throughout California. This landmark legislation makes it possible for Alto Ingredients and the broader renewable fuels industry to meet the growing demand for more affordable, domestically produced ethanol blends while supporting the state's clean energy goals.

Alto Ingredients, Inc. to Present in the 27th Annual H.C. Wainwright Global Investment Conference
globenewswire.com
2025-09-02 16:05:00PEKIN, Ill., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025, in New York City.

Victoria's Secret Has Opened Its New Flagship Store in Miami Beach, Marking a Bold New Chapter for the Iconic Brand
businesswire.com
2025-08-19 10:18:00MIAMI--(BUSINESS WIRE)--ALTO Real Estate Funds announced the opening of Victoria's Secret's flagship store. After relocating from a nearby site, Victoria's Secret secured a 12-year lease with ALTO Real Estate Funds — a move that underscores the strength of this premier property and Lincoln Road's global appeal. ALTO acquired the retail asset four years ago, during the height of the pandemic. Today, with Victoria's Secret anchoring the location, the property reflects the corridor's resurgence an.

Alto Ingredients, Inc. (ALTO) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-06 21:21:55Alto Ingredients, Inc. (NASDAQ:ALTO ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Bryon T. McGregor - CEO, President & Director Robert R.

Alto Ingredients (ALTO) Reports Q2 Loss, Beats Revenue Estimates
zacks.com
2025-08-06 18:21:09Alto Ingredients (ALTO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.05 per share a year ago.

Alto Ingredients, Inc. Reports Second Quarter 2025 Results
globenewswire.com
2025-08-06 16:05:00- Western Assets Increased Gross Profit by $5.6 Million, Compared to Q2 2024 - PEKIN, Ill., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended June 30, 2025.

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203
businesswire.com
2025-06-26 07:33:00MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the identification of a patient selection biomarker and positive pharmacodynamic results from its exploratory Phase 2 proof-of-concept (POC) trial of ALTO-203 in major depressive disorder (MDD) patients with elevated levels of anhedonia. ALTO-203 is a novel, oral, h.

Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder
businesswire.com
2025-05-29 08:03:00MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, in Scottsdale, Arizona, held May 27-30, 2025. ALTO-300, also known as agomelatine, is an oral, small molecule designed to act as a melatonin agonist and 5-HT2C antagonist be.

Alto Ingredients, Inc. (ALTO) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-05-07 22:50:45Alto Ingredients, Inc. (NASDAQ:ALTO ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations, Alliance Advisors IR Bryon McGregor - President & Chief Executive Officer Rob Olander - Chief Financial Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Operator Good day, and welcome to the Alto Ingredients First Quarter 2025 Financial Results Conference Call.

Alto Ingredients (ALTO) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
2025-05-07 19:20:36Alto Ingredients (ALTO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.17 per share a year ago.

Alto Ingredients, Inc. Reports First Quarter 2025 Results
globenewswire.com
2025-05-07 16:05:00- Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA -

Alto Ingredients, Inc. to Release First Quarter 2025 Financial Results on May 7, 2025
globenewswire.com
2025-05-01 08:30:00PEKIN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its first quarter 2025 financial results after the close of market on Wednesday, May 7, 2025.

Alto Ingredients, Inc. Directors to Not Stand for Reelection
globenewswire.com
2025-03-18 08:10:00PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that two long-standing directors, Douglas L. Kieta and Michael D. Kandris, have decided they will not stand for reelection to the Alto Ingredients Board of Directors at the company's 2025 Annual Meeting of Stockholders, scheduled for June 25, 2025.

Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok
globenewswire.com
2025-03-18 08:00:00PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that it has entered into a letter agreement (the “Letter Agreement”) with Bradley L. Radoff and Michael Torok (collectively with their affiliates, the “Radoff/Torok Group”), under which the Radoff/Torok Group has agreed that during the period commencing on the date of the Letter Agreement until the date that is the earlier to occur of (i) thirty (30) days prior to the deadline for delivery of notice under the Company's Amended and Restated Bylaws for the nomination of director candidates for election to the Board of Directors (the “Board”) at Alto Ingredients, Inc.'s (the “Company”) 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) or (ii) one hundred twenty (120) days prior to the first anniversary of the 2025 Annual Meeting of Stockholders of the Company, currently scheduled for June 25, 2025 (the “Standstill Period”), at each annual or special meeting of the stockholders of the Company, the Radoff/Torok Group will cause all shares of the Company's common stock beneficially owned by it in favor of all directors nominated by the Board for election and otherwise in accordance with the recommendations of the Board, and against the election of any director nominee not so recommended by the Board.

Alto Ingredients, Inc. (ALTO) Q4 2024 Earnings Call Transcript
seekingalpha.com
2025-03-05 19:13:24Alto Ingredients, Inc. (NASDAQ:ALTO ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors IR Bryon McGregor - President and CEO Rob Olander - CFO Conference Call Participants Sameer Joshi - H.C. Wainwright Eric Stine - Craig-Hallum Operator Good evening, and welcome to the Alto Ingredients Fourth Quarter and Year-End 2024 Financial Results Conference Call.